Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Nancy T. Chang files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Tracy W. Krohn - $527K of WTI open-market activity in the last 12 months
- Virginia Boulet - $212K of WTI open-market activity in the last 12 months
- Daniel O. Conwill IV - $205K of WTI open-market activity in the last 12 months
- Sameer Parasnis - $107K of WTI open-market activity in the last 12 months
- William J. Williford - $107K of WTI open-market activity in the last 12 months
- Huan Gamblin - $107K of WTI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Nancy T. Chang?
Nancy T. Chang is a corporate insider, tracked as Director, 10% Owner of Galera Therapeutics, Inc. (GRTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nancy T. Chang submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Nancy T. Chang been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($199K) across all tracked filings.
Where can I see all of Nancy T. Chang's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Nancy T. Chang and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial